Myovant Return on Average Assets Trend from 2010 to 2021

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

Myovant Sciences Return on Average Assets yearly trend continues to be fairly stable with very little volatility. Return on Average Assets will likely drop to -0.63 in 2021. During the period from 2010 to 2021, Myovant Sciences Return on Average Assets regression line of quarterly data had mean square error of 0.12 and geometric mean of  0.93. Myovant Sciences Research and Development Expense is fairly stable at the moment as compared to the past year. Myovant Sciences reported Research and Development Expense of 136.71 Million in 2020. Selling General and Administrative Expense is likely to climb to about 195.7 M in 2021, whereas Earning Before Interest and Taxes EBIT is likely to drop (263.7 M) in 2021.

Search Historical Trends 

 
Refresh
Check Myovant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myovant main balance sheet or income statement drivers, such as Cost of Revenue of 269.3 K, Gross Profit of 52.8 M or Interest Expense of 10.4 M, as well as many exotic indicators such as Asset Turnover of 0.12, Current Ratio of 2.92 or Free Cash Flow per Share of 4.42. Myovant financial statements analysis is a perfect complement when working with Myovant Sciences Valuation or Volatility modules. It can also supplement various Myovant Sciences Technical models. Additionally, see the analysis of Myovant Sciences Correlation against competitors.

Myovant Return on Average Assets Breakdown

Showing smoothed Return on Average Assets of Myovant Sciences with missing and latest data points interpolated. Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].Myovant Sciences' Return on Average Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myovant Sciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (35.36) %10 Years Trend
Decreasing
Stable
 Return on Average Assets 
Share
      Timeline 

Myovant Return on Average Assets Regression Statistics

Arithmetic Mean(0.97)
Geometric Mean 0.93
Coefficient Of Variation(35.00)
Mean Deviation 0.24
Median(0.87)
Standard Deviation 0.34
Sample Variance 0.12
Range 1.15
R-Value(0.17)
Mean Square Error 0.12
R-Squared 0.028097
Significance 0.60
Slope(0.015793)
Total Sum of Squares 1.27

Myovant Return on Average Assets History

2017 (1.03) 
2018 (1.57) 
2019 (1.72) 
2020 (0.58) 
2021 (0.63) 

About Myovant Sciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Myovant Sciences income statement, its balance sheet, and the statement of cash flows. Myovant Sciences investors use historical funamental indicators, such as Myovant Sciences's Return on Average Assets, to determine how well the company is positioned to perform in the future. Although Myovant Sciences investors may use each financial statement separately, they are all related. The changes in Myovant Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Myovant Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Myovant Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Myovant Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Return on Average Assets(0.58) (0.63) 
Average Assets440.4 M349.5 M
Average Equity-239.8 M-246.1 M
Invested Capital Average177 M191 M
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Myovant Sciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see the analysis of Myovant Sciences Correlation against competitors. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.